Markets

Commodities

Currencies

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference

aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update 

loader